Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|August 14, 2019
Population Pharmacokinetics of the Antituberculosis Agent PretomanidDavid H Salinger, Vishak Subramoney, Daniel Everitt, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A semi-mechanistic model to characterize the pharmacokinetics and pharmacodynamics of brodalumab in healthy volunteers and subjects with psoriasis in a first-in-human single ascending dose studyDavid H Salinger, Christopher J Endres, David A Martin, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2019
Daily Dosing for Bedaquiline in Patients with TuberculosisDavid H Salinger, Jerry R Nedelman, Carl Mendel, et al.
Journal of Clinical Pharmacology|October 18, 2008
Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology GroupJeannine S McCune, David H Salinger, Paolo Vicini, et al.
Pharmacogenetics and Genomics|November 3, 2009
Pharmacogenomic trial design: use of a PK/PD model to explore warfarin dosing interventions through clinical trial simulationDavid H Salinger, Danny D Shen, Kenneth Thummel, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with TuberculosisHanbin Li, David H Salinger, Daniel Everitt, et al.
Journal of Clinical Pharmacology|January 16, 2010
Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administrationDavid H Salinger, Paolo Vicini, David K Blough, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2014
Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administrationJeannine S McCune, Paolo Vicini, David H Salinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patientsDavid H Salinger, David K Blough, Paolo Vicini, et al.
Journal of Clinical Pharmacology|December 17, 2011
A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipientsHong Li, Donald E Mager, Meagan J Bemer, et al.
Pageof 3